Neurosurgery Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Neurosurgery is a surgical specialty concerned with the treatment of disorders and diseases related to the spinal cord, sympathetic and peripheral nervous system, and brain. Medications related to neurosurgical conditions include four drugs: Phenytek, Phenytoin Sodium, Dilantin, and Phenytoin. These are anti-epileptic drug or anticonvulsant. Epilepsy causes recurrent seizures that are unprovoked by neurologic insults or acute systemic. Phenytoin is used to control these seizures by slowing down brain impulses caused by this disorder. Seizures can occur due to bleeding in the brain caused by injuries, brain tumors, or brain surgery. Phenytoin sodium is included under the drug class Hydantoins. Phenytoin is a hydantoin derivative anticonvulsant drug. Phenytoin sodium is used to reduce neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures.
Long-term side effects of cerebellar ataxia and osteopenia, reduce their use by neurologists. Neurosurgery drugs have narrow therapeutic index and zero-order kinetics that makes these drugs to be one of the most difficult antiepileptic drugs to use. Moreover, these drugs are likely to have significant bidirectional drug interactions. Some neurosurgery drugs may cause difficulty in coordinating movements, confusion, headaches, nausea, dizziness, and drowsiness. If these drugs are ingested during pregnancy, they can causing various abnormalities in the baby.
The neurosurgery drugs market is driven by the rise in geriatric population with neurological disorders. The Global Campaign against Epilepsy sponsored by the International League against Epilepsy, the International Bureau for Epilepsy, and the World Health Organization advocates using phenobarbital to increase health promotions in low-income countries. This projected to boost the neurosurgery drugs market. According to the book Neurological Disorders, written by Rajesh Pandav, Ramanan Laxminarayan, Vijay Chandra, and others, states that a study conducted in developed countries on people who underwent epilepsy surgery indicated that 58% of them are seizure free, while 10% to 15% people have less frequent seizures, and even if the patients have less or no seizures, medications need to be continued for one to two years. This is projected to support the expansion of the neurosurgery drugs market. Statistics from the World Health Organization suggests that the global burden of neurological diseases was approximately 92 million disability-adjusted life years (DALYs) in 2005 and is estimated to reach 103 million DALYs by the end of 2030. Rapidly increasing burden of neurological diseases is likely to increase the number of neurological surgeries, thereby increasing the demand for neurosurgery drugs.
The neurosurgery drugs market can be segmented based on drug class, disease type, distribution channel, and region. In terms of drug class, the market can be categorized into hydantion anticonvulsants, and group I antiarrhythmics. Based on disease type, the neurosurgery drugs market can be classified into neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures. In terms of the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, and online pharmacies.
Based on geography, the neurosurgery drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America accounted for a large share of the market in 2016 owing to the increasing geriatric population and rise in research & development activities. Europe held the second large share of the market in 2016, due to rising stress levels and increasing inclination toward drug addiction for pain relief, which are expected to boost the demand for neurosurgery drugs. The market in Asia Pacific is anticipated to expand at a moderate pace during the forecast period owing to technological advancements and increasing stress levels in developed and developing countries. The market in Middle East & Africa and Latin America is projected to expand during the forecast period due to increasing health promotions in these countries.
Key players operating in the neurosurgery drugs market are Pfizer Inc., Sun Pharmaceutical Industries Limited, WOCKHARDT, and Mylan N.V.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017